methindione has been researched along with ruthenium in 1 studies
| Studies (methindione) | Trials (methindione) | Recent Studies (post-2010) (methindione) | Studies (ruthenium) | Trials (ruthenium) | Recent Studies (post-2010) (ruthenium) |
|---|---|---|---|---|---|
| 8 | 0 | 3 | 6,854 | 7 | 3,883 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habtemariam, A; Huang, Y; Li, X; Lin, Y; Luo, Q; Sadler, PJ; Wang, F; Wu, K; Xiong, S; Zheng, W | 1 |
1 other study(ies) available for methindione and ruthenium
| Article | Year |
|---|---|
Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
Topics: Amino Acid Sequence; Antineoplastic Agents; Binding Sites; Cysteine; Dose-Response Relationship, Drug; Glutathione S-Transferase pi; Humans; Indans; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; Molecular Structure; Organometallic Compounds; Protein Binding; Protein Structure, Tertiary; Ruthenium; Ruthenium Compounds | 2013 |